Nishindai H, Yoshimoto M, Nakanishi Y, Hashimoto I, Sawada Y, Nakamura T, Mikami J, Fugono T, Maeda K
Jpn J Antibiot. 1985 Jun;38(6):1571-86.
Cefotiam dihydrochloride (CTM) in a dose of 2 g was given by intravenous bolus injection to 15 patients operated upon for acute or subacute abdominal organs. They were included to 5 cases of acute localized peritonitis due to perforative appendicitis, 3 of diffuse peritonitis due to perforative duodenal ulcer, 1 of diffuse peritonitis with intestinal obstruction, 1 of perforative sigmoid colon cancer, 2 of gastric cancer or polyp with cholelithiasis, and 3 of cholangitis with cholecyst-choledocholithiasis. The materials of exudate from drain were taken at intervals by sterilized paper disc and determined by paper disc bioassay method with Proteus rettgeri ATCC 9250 or Proteus mirabilis ATCC 21100 as the test organisms to CTM concentrations. CTM concentrations in purulent exudate from drain of patients with acute peritonitis, they were increased quickly after intravenous bolus injection, and reached higher levels at early time after injection in cases 2 or 3 days after operation. CTM concentration in purulent exudate from drain was tended to increase in proportion to the severity of the inflammation. The CTM levels in infected exudate were higher than the MICs against clinically isolated organisms for a long time after administration. Therefore, CTM was very useful drug when used for chemotherapy of postoperative peritonitis.
对15例接受急性或亚急性腹部器官手术的患者静脉推注2g盐酸头孢替安(CTM)。其中包括5例因穿孔性阑尾炎引起的急性局限性腹膜炎、3例因十二指肠溃疡穿孔引起的弥漫性腹膜炎、1例伴有肠梗阻的弥漫性腹膜炎、1例乙状结肠癌穿孔、2例患有胃癌或息肉并伴有胆结石、3例患有胆囊炎并伴有胆囊胆管结石。每隔一段时间用无菌纸盘采集引流液样本,以雷氏普罗威登斯菌ATCC 9250或奇异变形杆菌ATCC 21100作为测试菌,采用纸盘生物测定法测定CTM浓度。急性腹膜炎患者引流液脓性渗出物中的CTM浓度,在静脉推注后迅速升高,并在术后2或3天的早期达到较高水平。引流液脓性渗出物中的CTM浓度往往与炎症的严重程度成正比。给药后很长一段时间,感染渗出物中的CTM水平高于对临床分离菌的最低抑菌浓度。因此,CTM用于术后腹膜炎化疗时是一种非常有用的药物。